Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials

Amirhossein Sahebkar, R. Giua, C. Pedone

    Research output: Contribution to journalArticlepeer-review

    13 Citations (Scopus)

    Abstract

    © 2016 The British Pharmacological SocietyObjectives: The effects of statins on insulin sensitivity, metabolic homeostasis and adipokines in humans are controversial. Several studies have investigated the impact of statin therapy on plasma leptin concentrations but the results have been inconsistent. The aim of the present study was to conduct a systematic review and meta-analysis of available evidence to calculate the effect size of statin therapy in changing serum leptin concentrations. Methods: A systematic search in PubMed-Medline, SCOPUS, Web of Science and Google Scholar databases was performed to identify randomized placebo-controlled trials investigating the effect of statins on plasma leptin concentrations. A random-effects model and generic inverse variance method were used for meta-analysis. Sensitivity analysis, risk-of-bias evaluation and publication bias assessment were carried out using standard methods. Random-effects meta-regression was used to evaluate the impact of treatment duration on the estimated effect size. Results: Six trials, with a total of 425 subjects, met the eligibility criteria. Overall, statin therapy had no significant effect on leptin levels (weighted mean difference -0.32 ng ml–1, 95% confidence nterval: -2.94, 2.30, P = 0.813). This effect was robust in the sensitivity analysis and in subgroup analyses of trials with
    Original languageEnglish
    Pages (from-to)1674-1684
    Number of pages11
    JournalBritish Journal of Clinical Pharmacology
    Volume82
    Issue number6
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Dive into the research topics of 'Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials'. Together they form a unique fingerprint.

    Cite this